INCY vs RANI · P/E 14, rev $5.14B vs rev $3.4M
Incyte Corporation (INCY) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. RANI currently screens at market cap $41.5M.
Not investment advice. Open the INCY and RANI stock pages for the full models.
Not investment advice.